Skip to main content

Epitalon vs Humanin

Both Epitalon and Humanin are used for longevity. Here's how their evidence, dosing, and regulatory status actually compare.

Epitalon

Evidence C+

Epitalon (Epithalon, AEDG)

A synthetic tetrapeptide that reportedly upregulates telomerase activity. Russian longevity studies suggest mortality reductions but Western RCTs are absent.

View full Epitalon profile →

Humanin

Evidence B

Humanin (HN)

A 24-amino-acid mitochondrial-derived peptide with cytoprotective effects across Alzheimer's, diabetes, and atherosclerosis preclinical models. Endogenous levels decline sharply with age.

View full Humanin profile →

Side-by-Side

AttributeEpitalonHumanin
Evidence GradeC+B
FDA StatusNot FDA-approved — Russian-origin research peptideNot FDA-approved — mitochondrial-derived peptide research compound
Typical Dose5–10 mg daily for 10–20 days, cycled (subcutaneous)Research range: 0.5–1 mg subcutaneous (rare clinical use)
Clinics Indexed475
Categoriesanti-aging, longevitymitochondrial, longevity, neuroprotection

Key reported benefits — Epitalon

  • Telomerase upregulation (preclinical)
  • Sleep/circadian normalization
  • Anti-aging signals

Key reported benefits — Humanin

  • Cytoprotection
  • Anti-amyloid effects
  • Insulin sensitization

Educational use only

This comparison is for educational purposes and not medical advice. Peptide selection should be made with a licensed medical professional based on your individual goals, health history, and current evidence quality.

← Back to all comparisons